Heron Therapeutics's market cap is currently $261.60M. The company's EPS TTM is $-0.184; its P/E ratio is ―; Heron Therapeutics is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is $-0.03. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 127.04M	$ 107.67M	$ 86.35M	$ 88.64M	$ 145.97M
Gross Profit	$ 61.94M	$ 52.80M	$ 40.33M	$ 52.45M	$ 84.35M
Operating Income	$ -110.61M	$ -174.66M	$ -217.83M	$ -228.16M	$ -210.69M
EBITDA	$ -103.79M	$ -176.66M	$ -215.25M	$ -222.53M	$ -201.23M
Net Income	$ -110.56M	$ -134.52M	$ -217.66M	$ -224.43M	$ -204.75M
Balance Sheet
Cash & Short-Term Investments	$ 80.41M	$ 84.85M	$ 157.58M	$ 208.49M	$ 390.97M
Total Assets	$ 222.51M	$ 250.95M	$ 305.71M	$ 353.56M	$ 512.78M
Total Debt	$ 179.63M	$ 157.48M	$ 159.50M	$ 24.61M	$ 19.79M
Net Debt	$ 150.95M	$ 142.11M	$ 68.95M	$ -80.53M	$ -52.11M
Total Liabilities	$ 256.48M	$ 237.38M	$ 228.14M	$ 117.06M	$ 108.95M
Stockholders' Equity	$ -33.97M	$ 13.57M	$ 77.57M	$ 236.49M	$ 403.83M
Cash Flow
Free Cash Flow	$ -60.33M	$ -148.74M	$ -206.38M	$ -191.63M	$ -131.73M
Operating Cash Flow	$ -58.79M	$ -146.91M	$ -203.35M	$ -184.82M	$ -124.58M
Investing Cash Flow	$ 18.00M	$ -3.32M	$ 32.73M	$ 208.96M	$ -21.78M
Financing Cash Flow	$ 54.11M	$ 75.06M	$ 156.03M	$ 9.11M	$ 186.43M

Currency in USD

Heron Therapeutics Earnings and Revenue History

Income Statement >

Heron Therapeutics Debt to Assets

Balance Sheet >

Heron Therapeutics Cash Flow

Cash Flow >

Heron Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing